EGFR and non-small cell lung carcinoma: Many studies have demonstrated that apoptosis is involved in EGFR-TKI resistance; for example, FGL1 can mediate gefitinib resistance by reducing apoptosis in non-small cell lung cancer, and Yiqi Chutan Tang can target apoptosis and autophagy to relieve gefitinib resistance 29, 30.